Current Alzheimer Research, Volume 2 - Number 3

Editorial: Advances in Alzheimer Therapy: Something Old, Something New, Something Borrowed, Something Blue

, 2(3): 275 - 279

Nigel H. Greig, Debomoy K. Lahiri and Ezio Giacobini

DOI: 10.2174/1567205054367865

An Overview of Phenserine Tartrate, A Novel Acetylcholinesterase Inhibitor for the Treatment of Alzheimers Disease

, 2(3): 281 - 290

Nigel H. Greig, Kumar Sambamurti, Qian-sheng Yu, Arnold Brossi, Gosse B. Bruinsma and Debomoy K. Lahiri

DOI: 10.2174/1567205054367829

Memory Deficits Correlating with Acetylcholinesterase Splice Shift and Amyloid Burden in Doubly Transgenic Mice

, 2(3): 291 - 300

Tina M. Rees, Amit Berson, Ella H. Sklan, Linda Younkin, Steven Younkin, Stephen Brimijoin and Hermona Soreq

DOI: 10.2174/1567205054367847

Acetylcholinesterase-Amyloid-β-peptide Interaction: Effect of Congo Red and the Role of the Wnt Pathway

, 2(3): 301 - 306

Nibaldo C. Inestrosa, Alejandra Alvarez, Margarita C. Dinamarca, Tomas Perez-Acle and Marcela Colombres

DOI: 10.2174/1567205054367928

Cholinesterases: Roles in the Brain During Health and Disease

, 2(3): 307 - 318

Clive G. Ballard, Nigel H. Greig, Angela L. Guillozet-Bongaarts, Albert Enz and Sultan Darvesh

DOI: 10.2174/1567205054367838

Lessons from Darwin: Evolutionary Biologys Implications for Alzheimers Disease Research and Patient Care

, 2(3): 319 - 326

Robert E. Becker

DOI: 10.2174/1567205054367856

JLK Inhibitors: Isocoumarin Compounds as Putative Probes to Selectively Target the γ-Secretase Pathway

, 2(3): 327 - 334

Checler Frederic, Alves da Costa Cristine, Ayral Erwan, Andrau David, Dumanchin Cecile, Farzan Michael, Hernandez Jean-Francois, J. Martinez, Lefranc-Jullien Solveig, Marambaud Philippe, Pasini Andrea, Petit Agnes, Phiel Christopher, Robert Philippe, St George-Hyslop Peter and Wilk Sherwin

DOI: 10.2174/1567205054367874

Pharmacological Approaches of Neurofibrillary Degeneration

, 2(3): 335 - 341

Khalid Iqbal and Inge Grundke-Iqbal

DOI: 10.2174/1567205054367810

Atorvastatin Therapy Lowers Circulating Cholesterol but not Free Radical Activity in Advance of Identifiable Clinical Benefit in the Treatment of Mild-to-Moderate AD

, 2(3): 343 - 353

D. Larry Sparks, Marwan N. Sabbagh, Donald J. Connor, Jean Lopez, Lenore J. Launer, Suzana Petanceska, Patrick Browne, Dawn Wassar, Sherry Johnson-Traver and Jeff Lochhead

DOI: 10.2174/1567205054367900

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease

, 2(3): 355 - 365

Andis Klegeris and Patrick L. McGeer

DOI: 10.2174/1567205054367883

Possible Use of Autologous Stem Cell Therapies for Alzheimers Disease

, 2(3): 367 - 376

Kiminobu Sugaya

DOI: 10.2174/1567205054367919

Enhancing Central Nervous System Endogenous GLP-1 Receptor Pathways for Intervention in Alzheimers Disease

, 2(3): 377 - 385

TracyAnn Perry and Nigel H. Greig

DOI: 10.2174/1567205054367892

Webmaster Contact:
Copyright © 2018 Bentham Science